Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Considerations for Endpoints in Lung Transplant Clinical Trials: An ISHLT Consensus Statement

作者:John R. Greenland, Michael Perch, K. Halloran, Deborah J. Levine, Eric D. Morrell, Anna Reed, Ciara M. Shaver, Jonathan P. Singer, Stuart C. Sweet, Robin Vos, Shambhu Aryal, Nicholas Avdimiretz, Fay Burrows, Daniel R. Calabrese, Fiorella Calabrese, Sílvia Vidal Campos, M.P. Combs, Marc de Perrot, Göran Dellgren, Joshua M. Diamond, Thomas M. Egan, Patricia Ging, David V. Glidden, Martin Goddard, Soma Jyothula, Michael Keller, Hrishikesh S. Kulkarni, Johanna M. Kwakkel‐van Erp, Vibha N. Lama, Nándor Marczin, Tereza Martinu, Megan L. Neely, Scott M. Palmer, Caroline Patterson, Elizabeth N. Pavlisko, Christine Pham, Melissa Sanchez, Hans Henrik Lawaetz Schultz, Nicolaus Schwerk, Unmil Shah, M.G.S. Shashaty, L.G. Singer, Patrick J. Smith, Laurie D. Snyder, Melinda Solomon, Stijn E. Verleden, Veronique Verplancke, A. Zeevi, Jamie L. Todd · 发表于:The Journal of Heart and Lung Transplantation · 年份:2025 · DOI:10.1016/j.healun.2025.09.017 · 被引用次数:3 · 研究领域:Transplantation: Methods and Outcomes、Renal Transplantation Outcomes and Treatments、Organ and Tissue Transplantation Research